Paradigm Spine, LLC Announces Strategic Promotions and Hiring of Key Personnel to Ensure Long-Term Growth and Success

NEW YORK, March 14, 2012 /PRNewswire/ — Paradigm Spine, LLC, a leading provider of spinal implant technologies, announces the promotion and addition of key strategic personnel to strengthen operations and further position the Company for long-term growth.
Guntmar Eisen has been promoted to the position of President and Chief Operating Officer (“COO”). As co-founder of Paradigm Spine, LLC, he has extensive operating experience in the global spine industry.
Prior to founding Paradigm, he held positions of increasing responsibility in product development and commercial operations with Aesculap and Spine Solutions. He led several successful new product introductions, including the worldwide launch of PRODISC®. Guntmar is a graduate of HFU Hochschule Furtwangen University and is well prepared to lead the next phase of the company’s development, focusing on the introduction of the coflex® device to the U.S. market upon regulatory approval.
Steven Amelio has joined as the Company’s new Chief Financial Officer. Steven will lead all financial administration, business planning and budgeting functions, and will partner with the Executive Management Team on all operating and strategic initiatives.
Steven has 24 years of experience in the medical device industry with U.S. Surgical Corporation, Tyco Healthcare Group, L.P., and Covidien, PLC. He has held positions of increasing responsibility throughout his career, including Division Chief Financial Officer. Steven has been involved in all aspects of acquisitions, divestitures, and was instrumental in the purchase of technologies in minimally invasive, electro-surgical, orthopedic and bio-surgery segments. Most recently, Steven was the Chief Financial Officer for DeVilbiss Healthcare, LLC. Steve has an MBA in Finance and a BBA in Accounting from Iona College in New York.
Mark J. Suseck has joined as the Company’s new Vice President of Marketing. Mark will be responsible for providing executive leadership and management of all U.S. marketing activities, including product management, communications, market research, new product launch initiatives and sales force and surgeon training activities.Mark is a global marketing leader with demonstrated results in specialty devices and biopharmaceuticals. Mark has successfully led marketing efforts for Johnson & Johnson, sanofi-aventis and GE Healthcare in the areas of minimally invasive surgery, central nervous system disorders, oncology, diabetes, and cardiology. Mark earned his BA in economics from Rutgers College, with minors in Philosophy and Education. He has also completed the Executive Management Program at the University of Michigan. Mark is certified in Six Sigma Process Excellence and Digital Marketing. He has been a faculty presenter at the J&J Marketing Excellence Program, and is a former member and program director for the Conference Board Council of Marketing Executives.